The FDA rejected Novo Nordisk's biologics license application for icodec, citing questions about the manufacturing process for this once weekly insulin as well as its use by type 1 diabetes patients. But there are several high-profile FDA approvals in our recap of recent regulatory news.
In the ever-evolving landscape of state-based health insurance exchanges, the convergence of technology and customer service is reshaping how these exchanges operate. The increasing advent of automation and artificial intelligence (AI) is rapidly dismantling the traditional business model that relies on the siloing of technology and customer service centers.
This week, HHS issued its HTI-2 proposal — a new proposed rule to improve healthcare data sharing among providers, payers, patients and public health organizations. It comes just seven months after HHS issued its HTI-1 rule.
Through a new partnership, Cityblock will offer medical and behavioral health services to members with serious mental illness or substance use disorder in Alliance Health's Behavioral Health and Intellectual/Development Disability Tailored Plan.
Like in every other industry, AI is knocking on the doors of healthcare with solutions that promise to revolutionize delivery of care. Advancing from a pen-and-paper mindset to a digital revolution will require the use of bridge technology.
In this episode, we talk about hospital consolidation and recent Supreme Court decisions affecting healthcare. Companies and organizations mentioned in this episode are Risant Health, Kaiser Permanenete, Cone Health, Geisinger, General Catalyst, Summa Health, FDA, the Supreme Court.
No comments